Opportunity knocks

Skibar, Wolfgang
March 2007
ICIS Chemical Business;3/5/2007, Vol. 2 Issue 56, p22
Trade Publication
The article reports on the biotechnology industry in Great Britain. The author said that bioscience and biotechnology offer immense opportunities for creating wealth. The biotechnology sector in Great Britain is the biggest in Europe, and globally it is second only to the U.S. Industrial biotechnology, or white biotechnology, provides the gateway to a new era of sustainable manufacture with an impact on a broad range of industry sectors including chemicals and nutraceuticals.


Related Articles

  • A Catalyst for Change: Today and Tomorrow. Horth, Charles // Life Science Today;Dec2001, Vol. 2 Issue 6, p4 

    Discusses the changes in the periodical 'Life Sciences Today.' Features included in the journal; Trends in the pharmaceutical, biotechnology and nutraceutical industries; Schedule of events; Readership and content of the periodical.

  • "Like playing chess with no squares". Dietderich, Andrew // Crain's Detroit Business;6/5/2006, Vol. 22 Issue 23, p13 

    The article analyzes the potential of Michigan to become a biotech powerhouse. It is not an easy task for a state built on automotive and manufacturing capabilities to become a biotech powerhouse. When California-based think tank Milken Institute studied the major areas of biotech and life...

  • Montgomery County, MD: The Ideal Location for Biotech.  // BioPharm International;Dec2001, Vol. 14 Issue 12, p54 

    Focuses on the transformation of Montgomery County into an international business center for bioscience in Maryland. Percentage of bioscience companies in the country; Impact of the presence of National Laboratory in the area; Incentives offered by the country to the biotechnology companies.

  • Growing a new Oregon industry. Bunnenberg, Ann // Oregon Business Magazine;Sep2002, Vol. 25 Issue 9, p9 

    Discusses the potential of bioscience as a growth industry in Oregon. Richness of Oregon's supporting industry and academic infrastructure; Efforts of Peter Kohler to bring the Oregon Health and Science University into national prominence for its research and technology; Development of a...

  • Creative Solutions for Locating Life Science Firms. Jarvis, John W. // San Diego Business Journal;5/21/2001, Vol. 22 Issue 21, p22 

    Reports on the growth of the life science industry in San Diego, California. Estimated biotechnology firms and employees in the San Diego region; Relocation of biotechnology startups to traditional commercial markets like the Sorrento Valley and Carlsbad; Pharmaceutical firms that have...

  • Consultants steer Life Sciences Initiative. Schnitzler, Peter // Indianapolis Business Journal;8/26/2002, Vol. 23 Issue 24, p7A 

    Declares that true believers in the Central Indiana Life Sciences Initiative are certain the state is brimming with biotechnology opportunities. Goal of concentrating economic development around existing assets such as the Indiana University School of Medicine, Eli Lilly and Co. and the high...

  • Engineering propionibacteria as versatile cell factories for the production of industrially important chemicals: advances, challenges, and prospects. Guan, Ningzi; Zhuge, Xin; Li, Jianghua; Shin, Hyun-dong; Wu, Jing; Shi, Zhongping; Liu, Long // Applied Microbiology & Biotechnology;Jan2015, Vol. 99 Issue 2, p585 

    Propionibacteria are actinobacteria consisting of two principal groups: cutaneous and dairy. Cutaneous propionibacteria are considered primary pathogens to humans, whereas dairy propionibacteria are widely used in the food and pharmaceutical industries. Increasing attention has been focused on...

  • Life Science Initiative selects targets. Schnitzler, Peter // Indianapolis Business Journal;3/3/2003, Vol. 23 Issue 52, p3 

    Reports on the Central Indiana Life Sciences Initiative's narrowing of its aim to industry targets it believes offers Indiana residents the best biotechnology opportunities. Brookings Institution's concern over whether Indiana's objectives are specific enough; State's opportunities to develop...

  • Emergence of Biotech Age Requires New Infrastructure.  // Grand Rapids Business Journal;07/17/2000, Vol. 18 Issue 29, p4 

    Discusses the recommendations of a study on how Michigan should deal with the emerging biotechnology industry in the state. Soft investment in entrepreneurial assistance, training and mentoring programs; Industry collaboration and networking; Support for infrastructure for life sciences in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics